Cargando…
Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?
The emergence of COVID-19 has created a major health crisis across the globe. Invasion of SARS-CoV-2 into the lungs causes acute respiratory distress syndrome (ARDS) that result in the damage of lung alveolar epithelial cells. Currently, there is no standard treatment available to treat the disease...
Autores principales: | Warrier, Sudha, Mohana Sundaram, S, Varier, Lavanya, Balasubramanian, Ananthakrishnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647345/ https://www.ncbi.nlm.nih.gov/pubmed/34915433 http://dx.doi.org/10.1016/j.placenta.2021.12.005 |
Ejemplares similares
-
An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4
por: Varier, Lavanya, et al.
Publicado: (2023) -
Autologous mesenchymal stem cells offer a new paradigm for salivary gland regeneration
por: Marinkovic, Milos, et al.
Publicado: (2023) -
Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species
por: Nair, Syam, et al.
Publicado: (2021) -
Mesenchymal stem/stromal cells—a key mediator for regeneration after perinatal morbidity?
por: Mueller, Martin, et al.
Publicado: (2016) -
Mesenchymal stem cells for cartilage regeneration
por: Le, Hanxiang, et al.
Publicado: (2020)